Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease

Launched by CAIRO UNIVERSITY · Nov 20, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how effective two common pain relievers, acetaminophen and ibuprofen, are for treating mouth sores called recurrent aphthous ulcers in children with celiac disease. Celiac disease is a condition that affects how the body digests gluten, a protein found in foods like bread and pasta. This trial aims to better understand which medication helps these children feel better when they have painful mouth sores, as celiac disease can make it harder for their bodies to absorb some medications.

To be eligible for this study, children must have a confirmed diagnosis of celiac disease and experience recurrent mouth sores. However, children who are allergic to any of the medications being tested or whose parents cannot be easily contacted after treatment will not be included. Parents can expect to be involved in the process, which will help researchers gather important information about the best ways to manage pain from mouth sores in children with celiac disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - 1. Children with clinical diagnosis with a celiac disease.
• • 2. presence of recurrent apthous ulcers.
• Exclusion Criteria:
• • 1. History of allergy to any ingredient present in the drugs to be used for treatment.
• • 2. Children whose parents had no home or mobile phone to enable post-operative contact.
• • 3. Parent that who refuse to sign the informed consent.